NDATOPICALGEL
Approved
Oct 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BENZAMYCIN (erythromycin and benzoyl peroxide) by Bausch + Lomb is clinical pharmacology the exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug. First approved in 1984.
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Benzamycin is a fixed-dose combination topical gel containing erythromycin (macrolide antibiotic) and benzoyl peroxide (keratolytic agent) approved for acne vulgaris. Erythromycin provides antibacterial activity while benzoyl peroxide exerts keratolytic and desquamative effects, with the combination mechanism not fully elucidated but appearing synergistic in lesion reduction. This topical gel formulation represents a long-established dual-mechanism approach to mild-to-moderate acne management.
LOE Approaching
Product approaches loss of exclusivity with moderate competitive pressure (30/100), indicating potential team restructuring and shift toward generic or line extension strategies.
Mechanism of Action
CLINICAL PHARMACOLOGY The exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug. Benzoyl peroxide has a keratolytic and desquamative effect which may also contribute to its…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Benzamycin offers limited growth-trajectory career opportunities due to LOE-approaching status and minimal linked job openings (0 identified). Roles focus on defensive commercialization, market access optimization, and transition planning rather than launch or expansion activities.
Brand Manager
Worked on BENZAMYCIN at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.